Today NSPR ranks # as BUY CANDIDATE.
Today NSPR ranks # as BUY CANDIDATE.

NSPR stock InspireMD Inc

NSPR stock
InspireMD Inc

April 24, 2019
Change -1.84%
Chart period: 2019-01-25 - 2019-04-24
VOLUME
Buy
TREND
Buy

MV LONG
Buy

MV SHORT
Sell

PIVOT
Sell

MACD
Sell

Will NSPR stock price go up or down on Thu, 25 Apr 2019?

InspireMD Inc Forecast and Stock Analysis

Technical NSPR stock analysis for April 24, 2019.

Buy candidate since 2019-04-03 Loss -40.20%
Shorts 0.55% ( 2019-03-29 )
Cash n/a
Loans n/a
Beta 6.33
ROA -84.88

InspireMD Inc fell by -1.84% in the last day from $4.35 to $4.27 The price has fallen in 6 of the last 10 days and is down by -1.39% for this period. Volume has increased in the last day by 33 140 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 120 833 shares bought and sold for approximately $515 957.00.

Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the NSPR stock was $4.27. This is 1.84% less than the trading day before Tuesday, 23rd Apr 2019.

During day the stock fluctuated 6.97% from a day low at $4.20 to a day high of $4.49.

30 day high of the NSPR stock price was $8.43 and low was $0.13.
90 day high was $8.43 and low was $0.13.
52 week high for the InspireMD Inc - $8.43 and low - $0.13.

Trend

InspireMD Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 182.24% during the next 3 months and, with 90% probability hold a price between $4.90 and $23.66 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Tuesday April 16, 2019, which indicates further falls until a new bottom pivot has been found. InspireMD Inc gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's". InspireMD Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $4.61. On a fall, the stock will find some support from the long-term average at approximately $2.45. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

The stock currently holds a RSI14 at 25 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Access full RSI 14 and RSI 21 lists

Support & Resistance

InspireMD Inc finds support from accumulated volume at $4.19.

Support: $4.19 Price: $4.27 Resistance: $4.58

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.29 between high and low, or 6.97%. For the last week, the stock has had a daily average volatility of 7.95%.

InspireMD Inc is oversold on RSI14 (25). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stoploss: $4.04 (-5.50%) (This stock has very high daily movements and this gives very high risk. Low RSI14 is 25 which reduces the risk some. There is a sell signal from pivot top found 5 days ago.)

Overall risk:

Very Low Low Medium High Very High

Today NSPR ranks # as BUY CANDIDATE.
Today NSPR ranks # as BUY CANDIDATE.